Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors [Phase 1, Phase 2]
Open-label, single-center Phase 1/2 clinical trial evaluating combining surufatinib with temozolomide and S-1 as first-line therapy for adva…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
A recruiting clinical trial in China aims to study protein molecular characteristics and prognosis of cervical neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. [Phase 2]
Phase II trial evaluating dendritic cells loaded with autologous tumor homogenate as adjuvant vaccination in resected stage IV rare cancers;…
-
CLINICAL_TRIALS other · 2024-08-21Clinical Trial Update: Personalized PRRT of Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update for personalized peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors, currently active but n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor [Phase 2]
A Phase II clinical trial is evaluating Leflunomide for neuroendocrine tumors associated with multiple endocrine neoplasia type 1; the study…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective [EARLY_Phase 1]
An early-phase trial evaluates how 68Ga-DOTATATE PET/CT impacts clinical management of neuroendocrine tumors from the referring physicians' …
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
A Phase 2 clinical trial is evaluating nab-sirolimus in patients with well-differentiated neuroendocrine tumors of the gastrointestinal trac…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma [Phase 4]
Phase 4 trial evaluating liposomal irinotecan for neuroendocrine tumors. The study is currently not yet recruiting.
-
FDA approval · 2024-07-01FDA Approved: KIT FOR THE PREPARATION OF INDIUM IN 111 PENTETREOTIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a kit for the preparation of Indium-111 pentetreotide used in imaging neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 study is evaluating daily 5 mg versus 10 mg everolimus in patients with neuroendocrine tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating simultaneous hyperpolarized [1-13C]pyruvate and 18F-FDG PET/MRS in cancer patients is currently enrollin…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Observational Study on GEP-and Pulm-NET Treated at FPG
An observational clinical trial update describes a study of gastroenteropancreatic and pulmonary neuroendocrine tumors treated at Fondazione…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study
Feasibility study examining the use of video consultations for follow-up care in patients with neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor [NA]
The DIVIT study, a trial evaluating diet and vitamin supplementation in patients with neuroendocrine tumors, has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: 5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'
This completed clinical trial evaluated 5-HIAA levels in urine versus plasma in patients with serotonin-producing neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Optimal Feeding for NET Patients [NA]
A completed clinical trial evaluating optimal feeding strategies for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients
Clinical trial update on a multiparametric prognostic and predictive system to classify patients with neuroendocrine neoplasms grade 3 (NET …
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor [NA]
This entry notes the completion of a clinical trial evaluating a web-based tailored information and support program for patients with neuroe…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study [NA]
A randomized pilot study assessing a web-based tailored information and support program for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Surgical Intervention and the NETest [NA]
Clinical trial update for a surgical intervention study using the NETest in neuroendocrine tumors. Sponsor Wren Laboratories LLC indicates t…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors [Phase 2]
Phase II trial of pembrolizumab plus lenvatinib in advanced well-differentiated neuroendocrine tumors has completed with results posted.
-
FDA approval · 2023-10-26FDA Approved: NETSPOT — Supplemental Application (Advanced Accelerator Applications USA, Inc)
FDA approved a supplemental application for NETSPOT (68GA-DOTATATE) from Advanced Accelerator Applications USA, Inc, expanding the labeling …
-
FDA approval · 2023-07-27FDA Approved: GA-68-DOTATOC — Supplemental Application (UIHC P E T Imaging Center)
The FDA approved a supplemental application for GA-68-DOTATOC (edotreotide gallium-68) from the UIHC PET Imaging Center to use this radiopha…